Bio-Techne Profit Margin

Bio-Techne (TECH) currently reports a profit margin of 14.97% as of June 2026. That compares with 6.02% in the prior-year period — up 148.7% year over year. That is above the Healthcare sector average of 13.76%. Use the charts on this page to explore Bio-Techne's profit margin history and peer comparisons.

Bio-Techne's profit margin increased from 6.02% to 14.97% — a 148.7% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Bio-Techne's profit margin of 14.97% is higher than the Healthcare sector average of 13.76%. That is roughly 8.8% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Bio-Techne's current 14.97% should be judged against Healthcare norms (sector average: 13.76%) and against TECH's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of 14.97%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 13.76%. From there, open related valuation or income-statement pages for Bio-Techne, and consider following TECH for alerts when major investors trade the stock.